Shares of Haleon plc (LON:HLN - Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as GBX 431.82 ($5.50) and last traded at GBX 394.10 ($5.02), with a volume of 65438391 shares. The stock had previously closed at GBX 388.20 ($4.94).
Analyst Ratings Changes
Separately, Berenberg Bank raised their price objective on Haleon from GBX 456 ($5.80) to GBX 457 ($5.82) and gave the stock a "buy" rating in a research report on Friday, February 28th.
Read Our Latest Stock Report on HLN
Haleon Price Performance
The stock has a 50 day moving average price of GBX 388.70 and a 200-day moving average price of GBX 381.34. The company has a debt-to-equity ratio of 53.36, a current ratio of 0.84 and a quick ratio of 0.93. The stock has a market capitalization of £33.39 billion, a price-to-earnings ratio of 31.11, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19.
Haleon (LON:HLN - Get Free Report) last issued its earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.20) EPS for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. On average, analysts forecast that Haleon plc will post 19.5033282 earnings per share for the current year.
Haleon Increases Dividend
The business also recently announced a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Thursday, April 24th will be issued a GBX 4.60 ($0.06) dividend. This is a boost from Haleon's previous dividend of $2.00. This represents a yield of 1.18%. The ex-dividend date is Thursday, April 24th. Haleon's dividend payout ratio is presently 50.46%.
Haleon Company Profile
(
Get Free Report)
Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.
Haleon's portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.
Further Reading
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
